13F-HR filed by Artia Global Partners LP
Artia Global Partners LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 37 holding rows worth $279,810,279.
- Accession
- 0001937964-25-000003
- Filer
- CIK 1937964
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 37 entries on the cover page, a total value of $279,810,279 stated on the cover page (in dollars after the unit check, H1), rows summing to $279,810,276 with VALUE read as dollars as filed, 13F file number 028-23071. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC | 834203309 | COM | 494,424 | $22,224,359 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 463,840 | $19,504,472 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 219,719 | $18,350,931 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 229,785 | $17,622,212 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 200,000 | $17,204,000 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 200,000 | $17,204,000 | dollars as filed | put |
| NUVALENT INC COM | 670703107 | Stock | 204,045 | $15,972,643 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 162,255 | $13,282,194 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 56,400 | $13,271,484 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 190,752 | $12,498,071 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 284,190 | $12,430,471 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 255,318 | $11,856,968 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 167,939 | $11,594,509 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 293,851 | $11,342,649 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 100,000 | $9,006,000 | dollars as filed | put |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 162,976 | $8,725,735 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 11,311 | $6,956,265 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 45,000 | $6,142,500 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 50,000 | $4,301,000 | dollars as filed | call |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 90,279 | $3,632,823 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 50,000 | $2,799,000 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 45,765 | $2,339,964 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 102,900 | $2,315,250 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 53,930 | $1,948,491 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 100,000 | $1,917,000 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 54,515 | $1,640,902 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 216,700 | $1,614,415 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 40,000 | $1,568,000 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 421,359 | $1,474,756 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 54,285 | $1,395,124 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 80,380 | $1,346,365 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 50,000 | $1,335,000 | dollars as filed | put |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 6,305 | $1,163,903 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 20,811 | $1,152,305 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 7,440 | $1,024,265 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 172,226 | $883,519 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 16,650 | $768,731 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001937964-25-000003 | this filing | 2025-02-14 | acceptance time not in the bulk data set |